State Key Laboratory of Virology and Joint-Lab of Invertebrate Virology, Chinese Virus Resource and Bioinformatics Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
Virol Sin. 2012 Jun;27(3):145-53. doi: 10.1007/s12250-012-3241-1. Epub 2012 Jun 9.
Influenza virus is a continuous and severe global threat to mankind. The continuously re-emerging disease gives rise to thousands of deaths and enormous economic losses each year, which emphasizes the urgency and necessity to develop high-quality influenza vaccines in a safer, more efficient and economic way. The influenza subunit and VLP vaccines, taking the advantage of recombinant DNA technologies and expression system platforms, can be produced in such an ideal way. This review summarized the recent advancements in the research and development of influenza subunit and VLP vaccines based on the recombinant expression of hemagglutinin antigen (HA), neuraminidase antigen (NA), Matrix 2 protein (M2) and nucleocapsid protein (NP). It would help to get insight into the current stage of influenza vaccines, and suggest the future design and development of novel influenza vaccines.
流感病毒是对人类的持续且严重的全球性威胁。这种不断重现的疾病每年导致数千人死亡和巨大的经济损失，这强调了以更安全、更有效和更经济的方式开发高质量流感疫苗的紧迫性和必要性。流感亚单位和 VLP 疫苗利用重组 DNA 技术和表达系统平台，可以以这样一种理想的方式生产。本综述总结了基于血凝素抗原 (HA)、神经氨酸酶抗原 (NA)、基质 2 蛋白 (M2) 和核衣壳蛋白 (NP) 的重组表达的流感亚单位和 VLP 疫苗的最新研究进展。这有助于深入了解流感疫苗的现状，并为新型流感疫苗的设计和开发提供建议。
